UC BON.CAP.CERT. 12/24 AMD/ DE000HC7MTN1 /
14/11/2024 21:46:50 | Var.+0.040 | Denaro14/11/2024 | Lettera14/11/2024 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
169.160EUR | +0.02% | 169.160 Quantità in denaro: 400 |
169.180 Quantità in lettera: 400 |
ADVANCED MIC.DEV. D... | - - | 31/12/2024 | Call |
GlobeNewswire
01/09
Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
GlobeNewswire
27/08
Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CL...
GlobeNewswire
27/08
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
GlobeNewswire
26/08
Aura Biosciences Announces the Presentation of Phase 2 End of Study Data Evaluating Suprachoroidal A...